Mounjaro Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Ozempic Lawsuits Continue With Second US Mass Litigation Involving GLP-1 Drugs and Vision Loss

December 19, 2025

Top 3 Best-Selling Weight-Loss Drugs to Watch in 2025

September 10, 2025

Top 50 Best-Selling Drugs to Watch in 2025: Insights from 2024 Sales Data

Eli Lilly Powers Investor Confidence with New $15B Share Buyback Program

December 13, 2024

What Are the Top 10 Diabetes Medications? A Look at Recent Sales Trends

December 3, 2024

FDA Removes Eli Lilly’s Mounjaro and Zepbound from Shortage List Sparking Lawsuit from Compounders

October 10, 2024

GLP-1 Drugs Mounjaro, Zepbound, Wegovy Back in Stock After Extended Shortages

August 22, 2024

Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data

Eli Lilly’s Mounjaro Outperforms Novo Nordisk’s Ozempic in New Weight Loss Study

Eli Lilly Reaches Settlement with Totality MediSpa Over Sale of Compounded Mounjaro and Zepbound

Real Chemistry Introduces IRIS, an Information Hub for All Things GLP-1 Drugs

Oprah Hosts TV Special About GLP-1 Drugs for Weight Loss

Eli Lilly Partners with Amazon Pharmacy for Home Delivery of Drugs

Eli Lilly’s Oscars Commercial Takes Aim at Hollywood’s Use of Obesity Medicines for ‘Vanity’

LillyDirect: New Home Delivery Service for Eli Lilly’s Diabetes, Weight Loss and Migraine Drugs

January 5, 2024

Compounded Versions of Mounjaro Being Sold at Pharmacies and Spas Prompt Lawsuits

September 21, 2023

Next Page »